Trial Profile
Phase I trial of a telomerase cancer vaccine (TeloB-VAX) in hormone-refractory prostate cancer.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 26 Apr 2011
Price :
$35
*
At a glance
- Drugs TeloB-VAX (Primary)
- Indications Prostate cancer
- Focus Adverse reactions; Pharmacodynamics
- 26 Apr 2011 New trial record